funding Archives - Metrion Biosciences

Metrion Biosciences Appoints Mark Keogh as Non-Executive Director

Sophie Rose2021-04-19T08:01:56+00:00

Metrion Biosciences appoints Mark Keogh as Non-Executive Director Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth Cambridge, UK, 19 April 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh as a [...]

Metrion Biosciences Appoints Mark Keogh as Non-Executive DirectorSophie Rose2021-04-19T08:01:56+00:00

Metrion Biosciences closes £2.7m new equity financing

Sophie Rose2021-04-06T07:59:45+00:00

Metrion Biosciences closes £2.7m new equity financing • Financing led by Gresham House Ventures • Funds to be used to enhance Metrion’s Cambridge, UK ion channel drug discovery laboratories and capabilities and expand its presence in the USA • Maya Ward, Associate Director, Gresham House Ventures, appointed to Metrion Board of Directors Cambridge, UK, [...]

Metrion Biosciences closes £2.7m new equity financingSophie Rose2021-04-06T07:59:45+00:00

Metrion Biosciences closes funding round

Sophie Rose2019-04-01T08:22:36+00:00

Metrion Biosciences Closes Funding Round Includes investment from o2h Ventures Therapeutics Fund Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases Cambridge, UK, 01 April 2019: Metrion Biosciences Ltd (“Metrion”), the specialist ion channel contract research and drug discovery company, announced today that it has completed [...]

Metrion Biosciences closes funding roundSophie Rose2019-04-01T08:22:36+00:00

Metrion awarded £637k Innovate UK Biomedical Catalyst primer award

Sophie Rose2018-09-10T14:40:22+00:00

Metrion Biosciences awarded £637k funding under Innovate UK Biomedical Catalyst Primer Award for ion channel drug discovery • Funding will support project aiming to identify novel oral therapeutics for the auto-immune disease psoriasis • Adds to Innovate UK funding awarded in February 2018 for research on potassium channel inhibitors Cambridge, UK, 28 August 2018: Metrion [...]

Metrion awarded £637k Innovate UK Biomedical Catalyst primer awardSophie Rose2018-09-10T14:40:22+00:00